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ABSTRACT 
A synthetic method for preparation of mixed hydrogenated and 
fluorinated oils of general formula RF-CHz-CH=CH-RH in which the 
fluorinated and hydrogenated parts could be altered at will is 
described. For the first time, fluorinated oils which have a high 
capacity for oxygen have been microemulsified-using .a hydrogenated 
surfactant (ionic or non-ionic), opening new perspectives for the 
production of blood substitutes. 
INTRODUCTION 
Perfluorinated compounds have been widely used as blood 
substitutes for a variety of reasons : lack of availability of. 
matched blood (large demand, geographical isolation, refusa! to 
accept transfusion (Jehovah 1 s Witnesses) or in organ bank·s, etc,.). 
Various fluorinated derivatives have been developed that 
have bath a high capacity for absorbing oxygen, and are rapidly 
eliminated from the organism, The best known are perfluoro-decahy­
dronaphtaline (F-decaline) and perfluorotripropylamine (F,T.P.A,), 
However, when injected intravenously in the pure state, these 
substances lead to the formation of emboli. They must, therefore, 
be administered as emulsions of the oil in water type (Fluosol-DA) 
�sing emulsifying agents such as Pluronic F-68 (polyoxyethylene/ 
polyoxypropylene polymer, MW= 8350) or egg yolk phospholipids. 
Fluosol-DA has been employed in human studies, and appears to be 
a good blood substitute, although it bas to be kept refrigerated, 
as its long tenn stability is low. 
One way around this problem would be to use a microemulsion 
of the oil in water (0/W) type. Microemulsions have the double 
advantage of spontaneous formation and good long term stability(l).
However, in order to forma rnicroemulsion from a perfluori­
nated oil such as F-decaline, fluorinated surfactants are required. 
This due to the segregation between the fluorinated and hydrogena­
ted chains, which has been described by Mukerjee (2). This is true 
for both aqueous (), S) and non-aqueous media (6). Various examples 
of surfactants of general formula RFCOONa (
3, 4 ) or RF(OCHzCH2)nDH 
(5) have been described for the preparation of microemulsions
from fluorinated oils, These molecules are eliminated slowly from
the organism and liberate taxie fluoride ions, and sa they cannot
be employed as blood substitutes. At the present time, only hydro­
genated (non-ionic or amphoteric) surfactants types are biocom­
patible. 
We report here a synthetic method for preparation of mixed 
hydrogenated and fluorinated oils in which the fluorinated and 
hydrogenated parts could be altered at will. For the first time; 
these fluorinated oils which have a high capacity for oxygen havebeen 
microemulsified using a hydrogenated surfactant (ionic or non-ionic) 
opening new perspectives for the production of blood substitutes. 
RESULTS AND DISCUSSION 
We opted for the following type of molecule 
�-CH2-CR=CR-R,a
A Wittig reaction for fluoroalkylation carried out in a solid-liquid 
transfer phase has been described in previous publications (
7 , 8). 
It enabled us to vary the relative proportions of hydrogenated 
and fluorinated portions in the molecule. 
l ,c,",', p+ (CH2'2 R
,, 
+ RH CHO 
95°
C K,�9•----> R -CH -CH=CH-RH r dioxane/catalyst F 2 
.! 2 (water or formamide) 3 
We changed the groups RF and 111 by
i) using various fluoroalkyl iodides for synthesis of the phospho­
nium salts 1.
ii) and by using different aldehydes 2 = c
4H9
CHO, C
6
H
13
CHO, and
c8
H17CHO,
Table 1 shows the yields of the oils synthesized using these 
me thods. 
Phrsico-chemical_studx_of_mixed_oils 
In order to be used as blood substitutes, fluorinated 
compounds must fulfil the following criteria : 
i) High capacity for absorbing gases, especially oxygen
ii) Low toxicity due to rapid elimination from the body, mainly
via transpiration through the skin and lungs.
F-decaline fulfils the se cri te ria to the greatest extent (9)
TABLE 1 
Yields of oils synthesized by Wittig reaction 
(Z/E ratio = 70/30 ; -X- = -CH2CH=CH-)
OIL 
3a 
YIELD(%) 55 
3b 
35 
3c 
23 
3d 
30 
3e 
60 
and we have, therefore, included it in the followins studies for 
comparison (Table 2), 
We chose molecules of different degrees of fluorination and 
different chain lengths :
c
4
F
9
-cH2 -
CH=CH - CBH I 7
3e 
and CBFI 7-C
Hz- CH=CH - C4H9 3a 
The results presented in Table 2 show that : 
· i) The partially fluorinated oils have a good capacity for absor­
bing oxygen, similar to that of blood, although less than that of
F-decaline, The degree of fluorination seemed to have little
effect on oxygen solubility.
ii) The surface tensions of these compounds were lower than that
of F-decaline, especially for the more highly fluorinated compound
3a. It is likely that these oils are sufficiently volatile to be
TABLE 2 
Comparison of mixed hydrogenated/fluorinated oils with
F-decaline 
Blood F-decaline 3e 3a 
Solubili.ty of
Oz 37
° c, 20.6
x 
40.3x 25XX 25XX 
ml/lOOml 
surfaée 
tension 37 °c 19,7XXX 18.Bxxx 15.S xxx 
'�-N/-m 
x literature value (
9
) 
::}ii��i�·K-:�X measured using a Clark electrode. The electrode is immer_
;�:J
{
�
}�
;.:}n· _KÇl solution, separated from the test substance b y  a mem _
- "---�it�-�;)�;h�_t is permeable only to oxygen. The oxygen concentrationii�·<ééii.d.1ib�ium is recorded,
A9.)<qneasured using an automatically ·1·b · equi i rating surface 
/<ff tensiometer (Pro labo).
rapidly eliminated from the organism, However, we did not carry out 
out a toxicity study as they are insoluble in DMSO, which is the 
solvent used for intraperitoneal injections. Toxicity studies 
using microemulsions prepared from these oils are planned, 
Preparation of microemulsions from oils of ty�� RF
CH2CH=CH¾ ��igg
�Y�Eegenated surfactants 
The first attempts to Prepare microemulsions from these 
partially fluorinated oils used cetyltrimethylammonium bromide 
(C.T.A.B,) as surfactant and 1-butanol as cosurfactant. These 
agents are known for their ability to form microemulsions from 
hydrogenated oils (both oil-in-water 0/W, and water-in-oil W/0 
types) (1). 
We used a C.T.A.B./butanol ratio of l/2 which is widely 
used for hydrogenated oils. The results were encouraging as we 
obtained two microemulsion regions A and B in the. phase diagram 
of c8F17
-ctt
2
-CH=CH-C
4
H
9 
(Figure !).
All measurements were carried out at 37 °C. The two zones 
A and B corne closer together as the¾, chain length is reduced, 
and as the RH chain length is incieased. For c4
F
9
-cH
2
CH=CH-c
8
H
17
(Figures 2,3,4 and 5) zones A and B coalesce and the phase 
diagram resembles that of a totally hydrogenated oil. 
All the microemulsions were stable over a period of several months. 
This showed that microemulsions could be formed from the 
mixed fluorinated and hydrogenated oils using hydrogenated sur­
factants. However, we were keen to use non-taxie and hence non­
ionic compounds. We therefore replaced C,T.A.B. with non-ionic 
surfactants such as 
whose synthesis has been reported in a previous publication (IO), 
�igu�e 1. Phase diagram for system 
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H
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3
H
5
)
n 
- tOC2H41mOH 
( n a: 10, M ,.,,. 10r n = 10 , ln • 20)
ii) - Q�i�B_f�o non-ionic surfactants
Several trials using the oil c8F17cu2cn=CHC4H9 
(Figure 6)
were carried out. We obtained a small microemulsion zone in the 
water-rich region without using any cosurfactant, The area of 
this zone was similar for both surfactants, It is interesting 
that the microemulsion zone is situated in the water�rich region, 
where there is very little surfactant (0/W type). It would, there­
fore, be suitable for use as a blood substitute which has to be 
diluted in aqueous media. 
CONCLUSION 
We were able to produce microemulsions from partially fluo­
rinated oils using both hydrogenated ionic and non-ionic surfac·_ 
tants. Since oxygen was found to have a high solubility in these 
oils, they would be suitable for use as blood substitutes. Mixed 
fluorinated and hydrogenated oils could be developed with high 
capacity for oxygen. Microemulsions could be prepared from them 
using non-ionic high molecular weight surfactants of the Pluro­
nic type, which are currently used in biomedical applications. 
EXPERIMEHTAL 
A. Synthesis of mixed fluorinated and hydrogenated oils
Proton NMR spectra were recorded on a Varian T 60 apparaus 
at 60 MHz, and 19F spectra at 90 MHz on a Perkin Elmer R 32. Cherai
cal displacements (Ô) are expressed in ppm with respect ta TMS as 
internat standard for 1H and CF3COOH for 19F.
Elemental analyses were carried out by the CNRS microanaly­
sis in Lyon (France). The purity of the synthesized products was 
98 ± 0.3%. 
A.l. - �!�paration of partially_fluorinated phosphonium ��!E�
+ -
{C
6
H
5
)3 P CH2
CH
2
R,,, I
General method 
•0· ·1··�i;·�f'f1uoroalkyl iodide RpCH2CHzl (Atochem) and 0.1• m . 
rrole of triphenyl phosphine were heated and shaken without solvent 
at 95oc overnight for �F = c4Hg and for 6 h for R
p =
_C
6F13
, CaF17
. 
Th solid residue obtained was left to cool, washed 1n 
to�uene and then ether. The white solid remaining was dried under 
vacuum at 45
°
C, 
+ -
(C6
H
5
)
3 
p CH2
CH2
C4F9 I
Yield : 95% 
la 
RMN 
1H CD
3
COCD3 :
(2p, m, GHz a(.P), 
2. 72 (2p, unresolved, CH2 � P) ;
7.66 to 8.33 (15p, m (C6H5)3P). 
4.00 to 4.57 
lb 
Yield = 94% 
mtR 
1
H CD
3
COCD3 : 2.63 (2p
, m, CH2
7,40 to 8.40 (lSp, m, (C6
H
5)3P). 
+ 
(C
6
H
5
)3 
P CH
2
CH
2
c8F
17 
I le
Yield - 85% 
füfR IH cn
3
cocn
3 
: 2.73 (2p, m, CH
2
7.67 to 8.37 (lSp, m, (C6
H
5)3P). 
f?, P) 4.23 (2p, m, GHz o< P) 
� P) 4.27 (2p, m, CH2 o(.P) 
A,2, - PreEaration_of mixed_olefins 3 
Condensation_of_EhosEhonium halides_l_with_aldehydes 
General method 
All aldehydes were purchased from Aldrich (957. min, purity) 
0.025 mole of fluorinated phosphonium salt, 20 ml of dioxan-1, Lf 
anhydride, 0.02 mole�� aldehyde, 0.03 mole of potassium 
carbonate and 1,67, 10 - mole of water or forrrnmi<le are placed in 
a round bottomed flask. The reactants are shaken at 95
°
C for 2 h. 
The reaction mixture is then filtered, and the solvent evapora­
ted under vacuum. The residue is taken up in cyclopentane to 
remove most of the triphenylphosphine oxide. The cyclopentane 
phase is extracted with water to remove the dioxan, the cyclopen­
tane is evaporated and the residue is distilled under vacuum 
(I0-2 mm Hg). 
c8F17
CH
2-CH=CH-C4H9
3a 
Yield = 557. 
1 
RMN H cnc:
3 
: �-4 to 3.2 (2p, split triplet, cH2 oe:.F) ; 5 to G(2p, m, CH-CH) , 0,6 to 2,2 (9p, m, c4H9
). 
RMN 19F CDC1
3
: 7.5 (3f, CF3), 40 (2f, CF2o<CH2) 
; 48 to 50 (!Of,
(CF2)5; 53 (2f, CF2o<.cF3). 
3b 
Yield = 35%
1 
( 
. . 
RMN H CDCl : 2.4 to 3.2 2p, split triplet,
(2p, m, CH=èH) ; 0.8 ta 2.2 (9p, 3M, c4H9).19 
RMN F CFC13 : 6.5 (3f, 
CF3), 39.5 (2f, CF2(I0f (CF2l3l ; 53 (2f, CF2 CF3). 
c4F9CH2-CH=CH-C4H9
Yield = 23% 
3c 
CH2) 5.2 ta 6.2 
48 ta So 
RMN 
1
H CDC1
3 
: 2.3 ta 3.2 (2p, split triplet, CHz) ; 5 ta 6 (2p,
m, CH=CH) ; 0.6 ta 2.2 (9p, 3M, c4H9). 
19 
RMN F CDC1
3
: 6.5 (3f, CF3
), 40 (2f, CF2o(CH2
) ; 51 (2f, CF2
CH2
) ; 53 (2f, CF2o<.CF3
). 
c
4
F
9
CH
2
-CH=CH-C
8
H
17 
Yield = 60% 
3e 
NMR 
1
H CDc:3 
: �-4 ta 3.2 �2p, split triplet,
(2p, m, CH-CH) , 0.9 to 2.2 (l7p, 3m, c8H17) 
5.2 ta 6.1 
CH2) 
; 5.2 to 6,1
B. Determination of monophasic zones in the microemulsions
Surfaètants used were cetyltrimethylamrnonium bromide (C.T,A.B
Merck, 99% min. purity) anil ethoxylated nonylphenol 
C
9
H
19 
-v- (OC3H6)n - (OC2H4)m-OH (Seppic, 97% min, purity).
Cosurfactants was 1-butanol (Merck, spectroscopy grade, 
99/7% min. purity), 
Transparency criteria were used ta determine the monophasic 
microemulsion zone on the pseudoternary phase diagram. A visual 
method was used (11) at a temperature of 37 ± 0,1 °C, All systems 
were stable over a period of several months. 
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